Merontos, Menzl Mae V.
HRN: 13 21 16 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/28/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/28/2023
06/04/2023
IV
500mg
Q8
Amoebiasis
Checking Final Appropriateness
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes